A detailed history of Bellevue Group Ag transactions in Natera, Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 269,832 shares of NTRA stock, worth $29.9 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
269,832
Previous 256,584 5.16%
Holding current value
$29.9 Million
Previous $16.1 Million 53.55%
% of portfolio
0.39%
Previous 0.25%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$59.21 - $92.9 $784,414 - $1.23 Million
13,248 Added 5.16%
269,832 $24.7 Million
Q4 2023

Feb 14, 2024

SELL
$37.55 - $62.64 $41,380 - $69,029
-1,102 Reduced 0.43%
256,584 $16.1 Million
Q3 2023

Nov 14, 2023

BUY
$43.4 - $62.52 $1.08 Million - $1.56 Million
24,911 Added 10.7%
257,686 $11.4 Million
Q1 2023

May 15, 2023

BUY
$36.57 - $58.29 $2.16 Million - $3.44 Million
58,963 Added 33.92%
232,775 $12.9 Million
Q4 2022

Feb 14, 2023

BUY
$34.17 - $47.91 $5.94 Million - $8.33 Million
173,812 New
173,812 $6.98 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $10.7B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.